Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery.

This study developed a potential combinatory therapeutic strategy by regulation of TIME and a 'three-birds-one-stone'-like glioma-targeting drug delivery system.